Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution
- PMID: 18975280
- DOI: 10.1002/lt.21656
Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution
Comment on
-
Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.Liver Transpl. 2008 Feb;14(2):210-3. doi: 10.1002/lt.21417. Liver Transpl. 2008. PMID: 18236396
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical